News › Industry News, News, Patient Care

WeightWatchers Launches Program for Users of Ozempic and Other Weight-loss Drugs

December 18, 2023
Scale and measuring tape

For those who thought Ozempic would spell the end of diet programs, think again.

WeightWatchers launched WeightWatchers GLP-1, a subscription program focused on the health and nutrition needs of patients using Ozempic and Wegovy, two brands of semaglutide, a diabetes drug that has exploded in popularity for its effectiveness in helping people lose weight.

With its new membership offering, the 60-year-old diet company is hoping to stay relevant in a rapidly changing industry. Widespread use of Ozempic and Wegovy has upended the diet industry and even changed consumer eating habits. An estimated 24 million people, or 7% of the U.S. population, could be using the drugs by 2035, according to a report by Morgan Stanley Research.

Read more at CBS News >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • FDA Approves First New Sunscreen Ingredient in 20 Years
    • Allergan Aesthetics Releases ‘The Aesthetics Evolution: What Consumers Really Want’ Highlighting Consumer Motivations and Expectations in Aesthetics
    • Glendale Doctor Convicted in $45 Million Botox Fraud Scheme
    • Moxie Announces Treatment Plans
    • Pacific Reliance Medical M&A Advisors Becomes Platinum Vendor Affiliate with the American Med Spa Association